[Summery] As a result, Absolology has been able to cooperate with People Bio Co., Ltd. and Seoul National University Bundang Hospital to launch full-scale research to 'develop a high-sensitivity, point-of-care immunoassay platform for early diagnosis and staging of Alzheimer's using blood'.

http://www.bosa.co.kr/news/articleView.html?idxno=2172643

Excerpt from doctorsnews